
Twelve years of multiples investors have paid for Neogen Chemicals Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Neogen Chemicals Ltd trades at a P/E of 186.16× and P/B of 6.60×.
Twelve years of audited numbers for Neogen Chemicals Ltd, switchable between annual and quarterly views, consolidated or standalone.
Neogen Chemicals Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹5,434.62 Cr and reported EPS of ₹10.98.
| Period | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 239 | 306 | 336 | 487 | 686 | 691 | 778 | 862 |
| Other Income | 1 | 0 | 0 | 1 | 4 | 7 | 4 | 6 |
| Total Income | 240 | 306 | 337 | 488 | 691 | 698 | 782 | 868 |
| Cost of Goods Sold (COGS) | 141 | 184 | 198 | 275 | 389 | 382 | 423 | 466 |
| Gross Profit | 98 | 122 | 139 | 212 | 298 | 308 | 355 | 396 |
| +Operating Expenses | 55 | 64 | 74 | 126 | 186 | 198 | 218 | 258 |
| EBITDA | 43 | 58 | 64 | 87 | 112 | 110 | 136 | 138 |
| +Non-Operating Expenses | 15 | 17 | 21 | 31 | 45 | 65 | 62 | 103 |
| Profit Before Tax (PBT) | 29 | 41 | 44 | 57 | 71 | 53 | 50 | 41 |
| +Tax Expense | 8 | 12 | 13 | 12 | 21 | 17 | 15 | 12 |
| Profit After Tax (PAT) | 21 | 29 | 31 | 45 | 50 | 36 | 35 | 29 |
| Earnings Per Share (EPS) | 8.98 | 12.28 | 13.43 | 17.90 | 20.04 | 13.51 | 13.20 | 10.90 |
| Diluted Shares Outstanding (Nos.) | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
| +Additional Disclosures | 351 | 449 | 491 | 706 | 1,009 | 1,028 | 1,140 | 1,294 |
| Sales Growth % | — | 28.05 | 9.90 | 44.84 | 40.83 | 0.65 | 12.58 | 10.85 |
| YoY Sales Growth % | — | 28.05 | 9.90 | 44.84 | 40.83 | 0.65 | 12.58 | 10.85 |
| Material Cost % | 67 | 74 | 54 | 71 | 71 | 69 | 65 | 74 |
| Employee Cost % | 5 | 6 | 6 | 6 | 7 | 9 | 8 | 10 |
| Other Cost % | 18 | 15 | 16 | 19 | 20 | 20 | 20 | 19 |
| OPM % | 18 | 19 | 19 | 18 | 16 | 16 | 18 | 16 |
| Tax % | 28 | 30 | 29 | 22 | 30 | 33 | 31 | 30 |
| Profit Growth % | — | 36.80 | 9.34 | 42.44 | 11.97 | -28.66 | -2.30 | -17.46 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Fields | 41 | 53 | 57 | 75 | 95 | 87 | 109 | 110 |
Disclosed business segments at Neogen Chemicals with their share of revenue and profit, switchable between consolidated and standalone reporting.
Neogen Chemicals discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Why someone would buy Neogen Chemicals Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Neogen Chemicals Ltd's investment case rests on 7 positive markers and 11 flagged concerns drawn from the latest reported filings.
Neogen Chemicals maintains a strong promoter holding of 51.2%, signaling high confidence in its future and reducing external shareholding risks. This ownership level suggests a long-term commitment to the company's success.
The company exhibits a healthy operating profit margin (OPM) of 17.5%, indicating efficient cost management and strong pricing power in the specialty chemicals industry. This profitability is a key financial health indicator.
Neogen Chemicals holds a substantial market capitalization of ₹3842 crore, signifying its considerable size and influence within the specialty chemicals sector. This large cap can attract investor interest and provide stability.
Operating in the growing specialty chemicals sector, Neogen benefits from a resilient market known for high margins. This strong industry positioning offers potential for sustained long-term growth and profitability.
The specialty chemicals sector, where Neogen operates, is experiencing robust growth driven by increasing demand across various end-user industries. This trend presents significant expansion opportunities for the company.
Neogen Chemicals has a high P/E ratio of 95.00, suggesting the stock may be overvalued relative to its earnings. Investors should carefully assess this valuation and the potential risks associated with such a high multiple.
The company's debt-to-equity ratio of 0.76 indicates a notable level of debt, which could elevate financial risk, particularly during economic downturns. This substantial debt requires close monitoring by investors.
Quarterly profit variability is a concern, with a recent -10.60% change in PAT. This volatility highlights the need for careful analysis of future earnings and potential impacts of market fluctuations on profitability.
A notable decrease in promoter holding from 60.19% to 51.22% warrants attention. Investors should monitor further changes, as this could signal shifts in company strategy or confidence, despite the current strong level.
The company exhibits low returns on equity (ROE) at 5.59% and capital employed (ROCE) at 8.82%. These figures are significantly lower than industry peers, indicating suboptimal capital efficiency and profitability.
Trim if P/E re-rates above 242. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 171.42. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Neogen Chemicals Ltd is highlighted for quick read-across.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Neogen Chemicals Ltd — derived from the live tape, not yesterday's close.
Neogen Chemicals Ltd last traded at ₹2,064.4 with an intraday range of ₹1,993–₹2,083.4 — live indicator, pivot and CPR signals below.
Standard pivot — most widely referenced.
| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 2281.67 | +217.27 | +10.52% |
| R3 | 2191.27 | +126.87 | +6.15% |
| R2 | 2137.33 | +72.93 | +3.53% |
| R1 | 2100.87 | +36.47 | +1.77% |
| PIVOT | 2046.93 | -17.47 | -0.85% |
| CURRENT | 2064.40 | — | — |
| S1 | 1829.67 | -234.73 | -11.37% |
| S2 | 1920.07 | -144.33 | -6.99% |
| S3 | 1956.53 | -107.87 | -5.23% |
| S4 | 2010.47 | -53.93 | -2.61% |
NEOGEN is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: 2033 ~ 2083.4
Trading Inside opening range
Daily traded volume and delivery percentage for Neogen Chemicals Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Neogen Chemicals Ltd stood at 33.6% of traded volume, against a 20-day average of 44.4%.
Filings Neogen Chemicals sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Neogen Chemicals files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 222 documents below.
Neogen Chemicals Limited has informed the Exchange about Schedule of meet
Neogen Chemicals Limited has informed the Exchange about Transcript
Neogen Chemicals Limited has informed the Exchange about Schedule of meet
Neogen Chemicals Limited has informed the Exchange about disclosure pursuant to regulation 30(9) read with Schedule III of the SEBI (Listing…
Neogen Chemicals Limited has informed the Exchange about Intimation to the Shareholders regarding Second 100 days Campaign Saksham Niveshak -…
Promoter, director and designated-employee transactions in Neogen Chemicals as reported to SEBI — buying and selling signals from the people who know the business best.
Neogen Chemicals insider activity below tracks 14 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| CADAMBA SOLUTIONS PRIVATE LIMITED | Insider | 18 Apr 2026 | buy | +10.00 L | ₹161 Cr | ₹1,610.00 |
| CADAMBA SOLUTIONS PRIVATE LIMITED | Insider | 18 Apr 2026 | buy | +10.00 L | ₹161 Cr | ₹1,610.00 |
| CADAMBA SOLUTIONS PRIVATE LIMITED | Insider | 18 Apr 2026 | buy | +10.00 L | ₹161 Cr | ₹1,610.00 |
| CADAMBA SOLUTIONS PRIVATE LIMITED | Insider | 18 Apr 2026 | buy | +10.00 L | ₹161 Cr | ₹1,610.00 |
| HARIN HARIDAS KANANI | Insider | 30 Mar 2026 | buy | +13.19 L | — | — |
| HARIN HARIDAS KANANI | Insider | 30 Mar 2026 | buy | +13.19 L | — | — |
| HARIN HARIDAS KANANI | Insider | 30 Mar 2026 | buy | +13.19 L | — | — |
| HARIN HARIDAS KANANI | Insider | 30 Mar 2026 | buy | +13.19 L | — | — |
| HARIDAS THAKARSHI KANANI | Insider | 11 Apr 2025 | sell | −29.13 L | — | — |
| BEENA HARIDAS KANANI | Insider | 11 Apr 2025 | buy | +29.13 L | — | — |
Every dividend, stock split and bonus issue Neogen Chemicals has declared, sequenced by announce and record date.
Neogen Chemicals corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
What Neogen Chemicals Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Neogen Chemicals Ltd operates in the Basic Materials, listed as NSE: NEOGEN, BSE: 542665.

Neogen Chemicals Limited is an Indian specialty chemical manufacturer and supplier, established in 1989 and headquartered in Thane. Their primary business revolves around the production and sale of a diverse range of chemical compounds, catering to a broad spectrum of industrial sectors.
A significant portion of Neogen's product portfolio centers on organobromine compounds. This encompasses a wide variety of alkyl bromides, dibromoalkanes, and other bromine-based derivatives. They also offer specialty chloro compounds, organolithium compounds, and inorganic chemicals such as bromine compounds and lithium salts. The company's expertise extends to Grignard reagents and advanced intermediates, highlighting their proficiency in complex chemical synthesis.
Beyond the specific chemical compounds, Neogen provides a comprehensive suite of chemical services. This includes custom synthesis tailored to client-specific needs, along with contract manufacturing services for larger-scale production requirements. Their expertise covers various chemical reactions such as alkylation, acylation, and halogenation, showcasing their versatile capabilities in chemical transformation.
The company's diverse clientele spans a wide array of industries. Key sectors served include pharmaceuticals, agrochemicals, engineering, electronics, polymers, water treatment, construction, aroma chemicals, flavors and fragrances, and specialty polymers. Their global reach is demonstrated by exports to 31 countries, solidifying their position as a significant player in the international specialty chemicals market.
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
The current share price of Neogen Chemicals Ltd (NEOGEN) is ₹2,064.4. Today, the stock has gained by ₹30.70 (1.51%), trading in a range of ₹1,993 to ₹2,083.4. The stock opened at ₹2,080 with a trading volume of 1,11,918 shares.
Neogen Chemicals Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹5,434.62 crores, P/E ratio of 186.16, ROE of 3.58%, and ROCE of 8.82%. The dividend yield stands at 0.05%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Neogen Chemicals Ltd (NEOGEN) is ₹2,087.3, while the 52-week low is ₹966.7. Currently trading at ₹2,064.4, the stock is 98.0% away from its 52-week low and 1.1% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Neogen Chemicals Ltd stock at ₹2,064.4 depends on multiple factors. The stock is currently trading with a P/E ratio of 186.16 and P/B ratio of 6.60. Today's performance shows a gain of 1.51%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Neogen Chemicals Ltd offers a dividend yield of 0.05%, which means for every ₹100 invested at the current price of ₹2,064.4, you can expect to receive approximately ₹0.05 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Neogen Chemicals Ltd's key financial metrics include: P/E Ratio: 186.16, P/B Ratio: 6.60, ROE: 3.58%, ROCE: 8.82%, Dividend Yield: 0.05%, EPS: ₹10.98, Book Value: ₹309.59, and Debt-to-Equity: 170.92. The company's market cap stands at ₹5,434.62 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Neogen Chemicals Ltd stock opened at ₹2,080 and is currently trading at ₹2,064.4, showing a gain of ₹30.70 (1.51%). The intraday high is ₹2,083.4 and low is ₹1,993. The trading volume stands at 1,11,918 shares, indicating moderate market participation today.
Neogen Chemicals Ltd has a Price-to-Earnings (P/E) ratio of 186.16, which means investors are willing to pay ₹186.16 for every ₹1 of earnings. With an EPS of ₹10.98, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Neogen Chemicals Ltd (NEOGEN) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Peers, sector trends, screeners and strategy playbooks contextual to this stock.